Article

WuXi Biologics won six awards at the 2026 Asia-Pacific Biopharma Excellence Awards, achieving a record for the most awards received in a single year. The company was recognized in categories such as Best Contract Development & Manufacturing Organization and Excellence in Bioprocessing Automation & Digitalization.

Dr. Sherry Gu was honored as CTO of the Year for her leadership in biologics development, while Dr. Jeremy Guo received the award for Head of Fill-Finish & Formulation of the Year. These accolades reflect WuXi's commitment to quality and innovation in bioprocessing and manufacturing.